FLAVONE

FLAVONE is a lipid of Polyketides (PK) class. Flavone is associated with abnormalities such as Cardiovascular Diseases, Cerebrovascular accident, DERMATITIS HERPETIFORMIS, FAMILIAL, Hyperinsulinism and Inflammatory disorder. The involved functions are known as Oxidation-Reduction, Metabolic Inhibition, Inflammation, Phosphorylation and antioxidant activity. Flavone often locates in Endothelium, Hepatic, Protoplasm, Body tissue and Extracellular. The associated genes with FLAVONE are ICAM1 gene, BCL2L1 gene, MYC gene, TP53 gene and cytochrome c''. The related lipids are Promega, Steroids and Total cholesterol. The related experimental models are Knock-out, Disease model and Animal Disease Models.

Cross Reference

Introduction

To understand associated biological information of FLAVONE, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with FLAVONE?

FLAVONE is suspected in Diabetes Mellitus, Non-Insulin-Dependent, Obesity, Chronic Disease, Disintegration, Cardiovascular Diseases, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with FLAVONE

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Stomach Ulcer D013276 75 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Pain D010146 64 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Per page 10 20 50 | Total 32

PubChem Associated disorders and diseases

What pathways are associated with FLAVONE

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with FLAVONE?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with FLAVONE?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with FLAVONE?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with FLAVONE?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with FLAVONE?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011) and Knock-out are used in the study 'How can research on plants contribute to promoting human health?' (Martin C et al., 2011).

Disease model

Disease model are used in the study 'How can research on plants contribute to promoting human health?' (Martin C et al., 2011).

Animal Disease Models

Animal Disease Models are used in the study 'How can research on plants contribute to promoting human health?' (Martin C et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with FLAVONE

Download all related citations
Per page 10 20 50 100 | Total 1492
Authors Title Published Journal PubMed Link
Xia C et al. Differential effect of Shenmai injection, a herbal preparation, on the cytochrome P450 3A-mediated 1'-hydroxylation and 4-hydroxylation of midazolam. 2009 Chem. Biol. Interact. pmid:19557931
Brunskole M et al. Trihydroxynaphthalene reductase of Curvularia lunata--a target for flavonoid action? 2009 Chem. Biol. Interact. pmid:19010313
Khan MS et al. Methylated chrysin induces co-ordinated attenuation of the canonical Wnt and NF-kB signaling pathway and upregulates apoptotic gene expression in the early hepatocarcinogenesis rat model. 2011 Chem. Biol. Interact. pmid:21554863
Lanoë PH et al. Cyclometallated platinum(II) complexes incorporating ethynyl-flavone ligands: switching between triplet and singlet emission induced by selective binding of Pb2+ ions. 2008 Chem. Commun. (Camb.) pmid:18802561
Liu B et al. A step toward simplified detection of serum albumin on SDS-PAGE using an environment-sensitive flavone sensor. 2015 Chem. Commun. (Camb.) pmid:26068596
Asakawa T et al. PET imaging of nobiletin based on a practical total synthesis. 2011 Chem. Commun. (Camb.) pmid:21243163
Khoobi M et al. A facile route to flavone and neoflavone backbones via a regioselective palladium catalyzed oxidative Heck reaction. 2012 Chem. Commun. (Camb.) pmid:22318701
Kanho H et al. Biotransformation of benzaldehyde-type and acetophenone-type derivatives by Pharbitis nil hairy roots. 2005 Chem. Pharm. Bull. pmid:15802832
Kesava Reddy M et al. A new chalcone and a flavone from Andrographis neesiana. 2003 Chem. Pharm. Bull. pmid:12843595
Wu LZ et al. Two new flavone C-glycosides from Trollius ledebourii. 2011 Chem. Pharm. Bull. pmid:22041076
Phrutivorapongkul A et al. Studies on the chemical constituents of stem bark of Millettia leucantha: isolation of new chalcones with cytotoxic, anti-herpes simplex virus and anti-inflammatory activities. 2003 Chem. Pharm. Bull. pmid:12576653
Herath W et al. Microbial metabolism. Part 6. Metabolites of 3- and 7-hydroxyflavones. 2006 Chem. Pharm. Bull. pmid:16508185
Maheswara M et al. Two new 5-deoxyflavonoids from Calliandra inermis. 2004 Chem. Pharm. Bull. pmid:15304993
Waki T et al. Key role of chemical hardness to compare 2,2-diphenyl-1-picrylhydrazyl radical scavenging power of flavone and flavonol O-glycoside and C-glycoside derivatives. 2012 Chem. Pharm. Bull. pmid:22223373
Chokchaisiri R et al. Bioactive flavonoids of the flowers of Butea monosperma. 2009 Chem. Pharm. Bull. pmid:19336944
Murata T et al. Hyaluronidase inhibitors from Keiskea japonica. 2012 Chem. Pharm. Bull. pmid:22223383
Ragab FA et al. Synthesis and anticonvulsant activity of certain substituted furochromone, benzofuran and flavone derivatives. 2010 Chem. Pharm. Bull. pmid:20823592
Herath W et al. Microbial metabolism part 9. Structure and antioxidant significance of the metabolites of 5,7-dihydroxyflavone (chrysin), and 5- and 6-hydroxyflavones. 2008 Chem. Pharm. Bull. pmid:18379084
Alam MS and Lee DU Facile synthesis and antibacterial activity of naturally occurring 5-methoxyfuroflavone. 2010 Chem. Pharm. Bull. pmid:21139271
Fernandes DC et al. Myeloperoxidase inhibitory and radical scavenging activities of flavones from Pterogyne nitens. 2008 Chem. Pharm. Bull. pmid:18451567
Hayashi T et al. A cytotoxic flavone from Scoparia dulcis L. 1988 Chem. Pharm. Bull. pmid:3246045
Wang XL et al. Effects of eleven flavonoids from the osteoprotective fraction of Drynaria fortunei (KUNZE) J. SM. on osteoblastic proliferation using an osteoblast-like cell line. 2008 Chem. Pharm. Bull. pmid:18175973
Moorthy NS et al. Synthesis, biological evaluation and in silico metabolic and toxicity prediction of some flavanone derivatives. 2006 Chem. Pharm. Bull. pmid:17015974
Goyal N et al. Ethynylflavones, highly potent, and selective inhibitors of cytochrome P450 1A1. 2014 Chem. Res. Toxicol. pmid:25033111
Fang H et al. Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. 2001 Chem. Res. Toxicol. pmid:11258977
Fang H et al. Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor. 2003 Chem. Res. Toxicol. pmid:14565775
Shimada T et al. Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives. 2010 Chem. Res. Toxicol. pmid:21053930
Shimada T et al. Reverse type I binding spectra of human cytochrome P450 1B1 induced by flavonoid, stilbene, pyrene, naphthalene, phenanthrene, and biphenyl derivatives that inhibit catalytic activity: a structure-function relationship study. 2009 Chem. Res. Toxicol. pmid:19563207
Tarling CA et al. The search for novel human pancreatic alpha-amylase inhibitors: high-throughput screening of terrestrial and marine natural product extracts. 2008 Chembiochem pmid:18214874
Goettert M et al. Biological evaluation and structural determinants of p38α mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids. 2010 Chembiochem pmid:21108268
Wang DJ et al. Effect of Total Flavone of Haw Leaves on Nuclear Factor Erythroid-2 Related Factor and Other Related Factors in Nonalcoholic Steatohepatitis Rats. 2018 Chin J Integr Med pmid:26919834
Guo AJ et al. Kaempferol as a flavonoid induces osteoblastic differentiation via estrogen receptor signaling. 2012 Chin Med pmid:22546174
Xu F et al. Quasi-MSn identification of flavanone 7-glycoside isomers in Da Chengqi Tang by high performance liquid chromatography-tandem mass spectrometry. 2009 Chin Med pmid:19630957
Tan W et al. Anti-cancer natural products isolated from chinese medicinal herbs. 2011 Chin Med pmid:21777476
Tang W et al. Simultaneous determination of eight major bioactive compounds in Dachengqi Tang (DT) by high-performance liquid chromatography. 2008 Chin Med pmid:18445276
Liu Z et al. Protective effect of chrysoeriol against doxorubicin-induced cardiotoxicity in vitro. 2009 Chin. Med. J. pmid:19951587
Cappelli C et al. Computational study of conformational and chiroptical properties of (2R,3S,4R)-(+)-3,3',4,4',7-flavanpentol. 2005 Chirality pmid:16196026
Goto S and Handa S Antithrombotic effects of flavonoid. 2001 Circulation pmid:11157735
Li GR et al. Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs. 2008 Circulation pmid:18458165
Mruk JS et al. Flavone-8-acetic acid (Flavonoid) profoundly reduces platelet-dependent thrombosis and vasoconstriction after deep arterial injury In vivo. 2000 Circulation pmid:10645930
Yan H et al. Treating senile dementia with traditional Chinese medicine. 2007 Clin Interv Aging pmid:18044136
Baguley BC Preclinical efficacy of vascular disrupting agents in non-small-cell lung cancer. 2011 Clin Lung Cancer pmid:21550553
Wurglics M and Schubert-Zsilavecz M Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients. 2006 Clin Pharmacokinet pmid:16640452
Li Y et al. Induction of apoptosis and inhibition of c-erbB-2 in breast cancer cells by flavopiridol. 2000 Clin. Cancer Res. pmid:10656453
Motwani M et al. Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells. 2000 Clin. Cancer Res. pmid:10741717
Manna SK et al. Morin (3,5,7,2',4'-Pentahydroxyflavone) abolishes nuclear factor-kappaB activation induced by various carcinogens and inflammatory stimuli, leading to suppression of nuclear factor-kappaB-regulated gene expression and up-regulation of apoptosis. 2007 Clin. Cancer Res. pmid:17404114
Kestell P et al. Measurement of plasma 5-hydroxyindoleacetic acid as a possible clinical surrogate marker for the action of antivascular agents. 2001 Clin. Chim. Acta pmid:11718691
Lefort EC and Blay J The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells. 2011 Clin. Exp. Metastasis pmid:21298326
Jeon SB et al. Flavone inhibits vascular contraction by decreasing phosphorylation of the myosin phosphatase target subunit. 2007 Clin. Exp. Pharmacol. Physiol. pmid:17880363
Buchanan CM et al. DMXAA (Vadimezan, ASA404) is a multi-kinase inhibitor targeting VEGFR2 in particular. 2012 Clin. Sci. pmid:22142330